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Abstract
Calpain-3 is an intracellular cysteine protease, belonging to Calpain superfamily and pre-
dominantly expressed in skeletal muscle. In human melanoma cell lines and biopsies, we
previously identified two novel splicing variants (hMp78 and hMp84) of Calpain-3 gene
(CAPN3), which have a significant lower expression in vertical growth phase melanomas
and, even lower, in metastases, compared to benign nevi. In the present study, in order to
investigate the pathophysiological role played by the longer Calpain-3 variant, hMp84, in
melanoma cells, we over-expressed it in A375 and HT-144 cells. In A375 cells, the enforced
expression of hMp84 induces p53 stabilization, and modulates the expression of a few p53-
and oxidative stress-related genes. Consistently, hMp84 increases the intracellular produc-
tion of ROS (Reactive Oxygen Species), which lead to oxidative modification of phospholip-
ids (formation of F2-isoprostanes) and DNA damage. Such events culminate in an adverse
cell fate, as indicated by the decrease of cell proliferation and by cell death. To a different
extent, either the antioxidant N-acetyl-cysteine or the p53 inhibitor, Pifithrin-α, recover cell
viability and decrease ROS formation. Similarly to A375 cells, hMp84 over-expression
causes inhibition of cell proliferation, cell death, and increase of both ROS levels and F2-iso-
prostanes also in HT-144 cells. However, in these cells no p53 accumulation occurs. In both
cell lines, no significant change of cell proliferation and cell damage is observed in cells
over-expressing the mutant hMp84C42S devoid of its enzymatic activity, suggesting that the
catalytic activity of hMp84 is required for its detrimental effects. Since a more aggressive
phenotype is expected to benefit from down-regulation of mechanisms impairing cell growth
and survival, we envisage that Calpain-3 down-regulation can be regarded as a novel
mechanism contributing to melanoma progression.
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Introduction
Calpains (Clan CA-C2, EC 3.4.22.17) constitute a superfamily of Ca2+-regulated, intracellular
cysteine proteases, evolutionarily well-conserved from bacteria to mammals. On the basis of
their domain structure, a complex classification of calpains and calpain homologs, divided into
“classical” and “non-classical”, has been recently proposed [1]. In humans, 9 out of the 15 cal-
pain genes code for classical calpains, with alternative splicing variants also generated. On the
basis of expression profile, 6 out of the 15 mammalian genes are considered to be tissue-
specific, and defects of the corresponding calpains have been associated with tissue-specific
pathological phenotypes. Among these calpains, particular emphasis has been placed on
CAPN3 gene product, Calpain-3 (or p94), predominantly expressed in skeletal muscle. It
proves to be crucial for muscle cell homeostasis, as demonstrated in Limb-Girdle Muscular
Dystrophy type 2A (LGMD2A, or calpainopathy), which is characterized by different CAPN3
point mutations and by muscle hypotrophy, hypoplasia and myonuclear apoptosis [2,3].
In melanoma cell lines and in melanoma biopsies, we have previously identified two novel
splicing variants of CAPN3, namely hMp78 and hMp84 (GenBank accession number:
EU91850 and EU91851, respectively) [4]. We demonstrated that both proteins are localized in
cytoplasm, and the autolytic cleavage form of the longer variant is also localized in nucleoli. In-
terestingly, among melanocytic lesions, the expression of these variants is significantly lower,
compared to benign nevi, in the most aggressive lesions, i.e. in vertical growth phase melano-
mas and, even lower, in metastases. Moreover, in cisplatin-treated melanoma cells, an in-
creased (auto)proteolytic activation of hMp84 variant occurs [4]. This event, in analogy with
the drug-induced activation of conventional calpains [5], suggested an active role of this iso-
form in the apoptotic machinery of melanoma cells.
A few papers from other Authors have pointed out a potential role of Calpain-3 in human
melanoma tumorigenesis and progression, as indicated by the higher expression levels of
CAPN3 in melanoma tissues compared to other tumor types [6], and by CAPN3 down-
regulation in melanoma cells sensitive to interferon-γ [7] or undergoing drug-induced terminal
differentiation [8]. More recently, Calpain-3 down-regulation has been also demonstrated in
the acquisition of a highly invasive metastatic phenotype [9]. Moreover, in an interesting study
of veterinary oncology, Calpain-3 has been shown to be activated in urothelial tumors of cattle
[10].
Against this background, in the present study we over-expressed the longer CAPN3 variant
(hMp84) in A375 and HT-144 melanoma cells, in order to better understand the pathophysio-
logical role played by Calpain-3 in melanoma cells, and the underlying biochemical and molec-
ular mechanisms regulated by this calpain. Our results demonstrate that over-expression of
hMp84 impairs cell proliferation and, concomitantly, induces cell death. As a mechanism re-
sponsible for cell damage, a redox imbalance, due to increased production of Reactive Oxygen
Species (ROS), is shown to play a major role.
Materials and Methods
Cell culture and treatments
Human melanoma A375 and HT-144 cells (from ATCC, cat. n. CRL-1619 and HTB-63, re-
spectively) (American Type Culture Collection, Manassas, VA) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) with 4.5 g/L glucose (Sigma-Aldrich, St. Louis, MO) and in
RPMI-1640 medium (Sigma), respectively, containing 10% heat-inactivated foetal bovine
serum (Invitrogen Life Technologies, Carlsbad, CA), 50 mg/L gentamycin, and 2 mM
L-glutamine, in a 37°C incubator, under 95% air and 5% CO2. For routine reseeding and for
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experiments, cells were harvested with PBS-EDTA 1 mM, pH 7.4. In selected experiments, cells
over-expressing the hMp84 variant of Calpain 3 and control cells transfected with empty vector
(produced as detailed below) were treated in fresh medium with 1 μM Pifithrin-α (PFT)
(Sigma-Aldrich) or 5 mM N-Acetyl-L-Cysteine (NAC) (Sigma-Aldrich). These compounds
have been preliminarily tested, in order to choose the lowest effective concentrations giving no
or minor toxicity in control cells.
At different experimental times, we harvested and analyzed the population of still adhering
cells together with or separately from the population of floating cells, depending on the investi-
gations to be performed, as specified in Results and Figure Legends. Cell proliferation was eval-
uated as total cells (adhering plus floating), counted in a Bürker chamber. The percentage of
floating on total cells was used as a first quantitative indication of cell damage.
hMp84 cloning, site-directed mutagenesis, and transient transfection
The human CAPN3 gene (hMp84 variant) was cloned from the human melanoma cell line
HT-144, previously characterized by us [4]. Total RNA was extracted by using RNeasy Mini
Kit (Qiagen, Valencia, CA) according to manufacturer’s instructions. cDNA was obtained
from 1 μg of total RNA by using High Capacity cDNA Reverse Transcription Kit and Oligo
dTs as primers (Invitrogen Life Technologies). hMp84 was amplified with specific primers (S1
Table) and cloned into pcDNA3.1(+) plasmid in BamHI-XhoI, by using E. coli (DH5α) as
host. Positive clones were sequenced to verify the absence of mutations. In order to mutate
hMp84 in the active site, Quickchange II XL site-directed mutagenesis kit (Agilent Technolo-
gies, Santa Clara, CA) was used, according to manufacturer’s instructions. Specific primers
(S1 Table) were designed to replace cysteine (at position 42) with serine. pcDNA3.1(+)-hMp84
was used as template. The resulting vector (pcDNA3.1(+)-hMp84C42S) was then sequenced to
verify the correct mutagenesis. DNA for transfection experiments was prepared using Qiafilter
Plasmid Maxi Kit (Qiagen), according to manufacturer’s instructions, in E. coli (DH5α) as
host. The resulting vector (containing wild or mutated hMp84) was used to transfect melano-
ma cells, by using Attractene Trasfection Reagent (Qiagen). Cells, seeded the day before, were
incubated with the transfectant mixture for 6 hours, then the medium was changed; the same
procedure was used for control cells, where the empty vector was employed.
To determine transfection efficiency, plasmids pEGFP-N2 (Clontech, Mountain View, CA)
and pEGFP-N2-hMp84, both containing the reporter gene for Enhanced Green Fluorescent
Protein (EGFP), were used. EGFP-expressing cells (at least 200 cells scored in each experiment)
were directly visualized by fluorescence microscopy (Nikon Eclipse Ti, Japan). The average
transfection efficiency was 40% and 30%, for A375 and HT-144 cells, respectively.
LDH release assay
The release of intracellular lactate dehydrogenase (LDH) in the culture medium was evaluated
by using LDH-P Kit (Sclavo Diagnostics International, Siena, Italy), according to manufactur-
er’s instructions, with minor modifications. An equal number of cells was seeded for all sam-
ples in each experiment, and the ratio of seeded cells/medium volume was kept constant
among different experiments. Forty μl of cell-free culture medium was collected for each sam-
ple and added to 160 μl of the assay mixture. LDH activity was measured at room temperature
in a microplate reader (Victor3 Multilabel Counter, Perkin-Elmer, Waltham, MA), absorbance
decrease was recorded at 340 nm over a period of 0.5–8 min, and results were expressed as
ΔAbs/min/10-3.
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Nuclear morphology analysis
Adhering and floating cells were collectively harvested and fixed at room temperature in 4%
paraformaldhehyde for 30 min. After a gentle centrifugation, fixed cells were stained with the
chromatin dye Hoechst 33342 (2 μM in RPMI without serum) (Sigma-Aldrich) for 30 min at
room temperature, and cell suspension was placed on a slide, with a coverslip over cells. The
nuclear morphology was observed under a fluorescence microscope (Nikon, Tokyo, Japan)
equipped with a DAPI filter. Images were captured with a CCD camera and imported into
NISElements Imaging software. At least 300 cells were scored for each sample in each experi-
ment. Apoptotic cells were detected as nuclei with condensed chromatin (brighter fluores-
cence), and as smaller or fragmented nuclei.
Fluorimetric assay for caspase-3/-7 activity
Caspase-3/-7 enzymatic activity was measured essentially as previously described [11]. Briefly,
the harvested (adhering plus floating) cells, after washing with PBS, were resuspended in ice-
cold lysis buffer (20 mMHepes-NaOH, pH 7.5, containing 10% sucrose, 0.1% CHAPS, 0.2%
NP-40, 1 mM EDTA, 5 mMDTT, 1 mM PMSF, and protease inhibitor cocktail (Sigma-
Aldrich)), and sonicated for 10 s (Vibracell Sonicator; amplitude 60, 25 W). After centrifuga-
tion, the supernatant of cell lysates (100 μg/ml of protein) were incubated at 25°C with the sub-
strate ac-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin (ac-DEVD-AMC, 40 μM) (Alexis
Enzo Life Sciences, Farmingdale, NY) in the assay buffer (lysis buffer, where Hepes and NP-40
were 100 mM and 0.1%, respectively). Cleavage of the fluorogenic substrate was monitored by
AMC release, in the microplate reader (excitation/emission wavelengths: 380/460 nm). Cas-
pase-3/-7 activity, determined in the linear portion of the progress curve, was expressed as Ar-
bitrary Units of Fluorescence (ΔAUFs)/min/mg protein.
Single-cell gel electrophoresis (Comet assay)
DNA damage was measured using the alkaline Comet assay, as described by Corti et al. [12].
At 24 h after transfection, harvested cells were suspended in 0.6% low melting point agarose. 2
x 104 cells were dispensed onto glass microscope slides previously coated with 1% normal melt-
ing point agarose, and the slides were left overnight in ice-cold lysis buffer (100 mM EDTA,
2.5 M NaCl, 10 mM Tris base, pH 10, containing 1% Triton X-100 (v/v) freshly added). After
washing with distilled water, slides were placed for 20 min in a horizontal electrophoresis tank,
containing ice-cold alkaline electrophoresis solution (300 mMNaOH, 1 mM EDTA), to allow
DNA unwinding. Electrophoresis was conducted for 20 min (30 V, 300 mA) at 4°C. Slides
were neutralised with 0.4 M Tris—HCl, pH 7.5 for 20 min, washed with distilled water, and
then allowed to dry. All procedures were carried out under subdued light to minimise back-
ground DNA damage. For staining, slides were re-hydrated in distilled water, incubated for 20
min with a freshly made solution of 2.5 μg/ml propidium iodide, washed again and allowed to
dry. Comets were visualised with a fluorescence microscope (Leica, Wetzlar, Germany) at 200×
magnification, and a total of 100 cells per sample (50 per duplicate slide) were analyzed. Images
were captured by an on-line Leica DFC320 camera, and the percentage of DNA in the comet
tail (% tail DNA), which quantifies the DNA damage, was calculated for each cell by the
CometScore software (TriTek Corporation, Sumerduck, VA).
Total F2-isoprostanes determination
The levels of total (free plus esterified) F2-isoprostanes (F2-IsoPs) in the cell suspensions were
determined by gas chromatography/negative ion chemical ionization tandem mass
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spectrometry (GC/NICIMS/MS). After 24 h of transfection, adhering cells were harvested with
PBS-EDTA 1 mM, pH 7.4 and the pellet was resuspended with the antioxidant butylated hy-
droxytoluene (BHT) (final concentration 90 μM); subsequently, the samples were sonicated for
30 seconds and then incubated at 45°C for 45 min in presence of 0.5 N KOH for the basic hy-
drolysis. The samples were then acidified to pH 3 with HCl (final concentration 0.5 N), and
spiked with tetradeuterated PGF2α (500 pg) as internal standard. After extraction with ethyl
acetate, the total lipids were applied to an aminopropyl (NH2) cartridge, and the final eluates
were derivatized to pentafluorobenzyl ester and trimethylsylil ethers and examined by GC/
NICI-MS/MS as previously reported [13]. Total F2-IsoPs levels were normalized for cell
protein content.
Measurement of ROS generation in intact cells
To assess the production of intra- or extra-cellular Reactive Oxygen Species (ROS) in intact
cells, two different fluorimetric assays were used, both performed in still adhering, viable cells,
in order to exclude any ROS formation as secondary event following cell death. Intracellular
production of ROS was measured by oxidation of 2’-7’-dichloro-fluorescin diacetate (H2DCF-
DA) to 2’-7’-dichloro-fluorescein (DCF). H2DCF-DA readily diffuses into cells, where it is de-
esterified into a non-fluorescent derivative and trapped within cells; when oxidated (by H2O2
and other oxidant species), it turns into the highly fluorescent DCF. Briefly, 3x104 cells were
seeded in 24-well plates, transfected, and left untreated or treated with NAC or PFT-α. At dif-
ferent time points, cells were washed with Krebs buffer containing 0.5 mM CaCl2 (KBC), incu-
bated for 30 min at 37°C in KBC containing 5 μMH2DCF-DA (Molecular Probes, Eugene,
OR), and then washed with KBC. Fluorescence was measured in the microplate reader (excita-
tion/emission wavelengths: 490/530 nm) for 60 min. Extracellular production of ROS was mea-
sured using the horseradish peroxidase-linked Amplex Red (A6550), which reacts with H2O2
to produce the fluorescent oxidation product, resorufin. Briefly, cells, prepared as above, were
incubated for 1 hour with 50 μMA6550 and 0.1 U/ml horseradish peroxidase type II, with or
without the inhibitor of NADPH oxidase, diphenylen iodonium chloride (DPI, 10 μM)
(Sigma-Aldrich). Fluorescence was subsequently measured in the microplate reader (excita-
tion/emission wavelenghts: 560/590 nm) for 90 min. ROS production was expressed as Arbi-
trary Units of Fluorescence (ΔAUF)/min/cell, where the actual cell number was evaluated in
each well at the end of the assays. A blank, run in KBC with all reagents and without cells, was
subtracted to all samples.
Western blot analysis
Cell lysates, as prepared for caspase activity assay, were subjected to SDS-PAGE and trans-
ferred to nitrocellulose membranes (AppliChem GmbH, Darmstadt, Germany). The mem-
branes, blocked in 10% non-fat milk in PBS-Tween 0.05% (PBST), were probed overnight at 4°
C with primary antibodies diluted in PBST-1% non-fat milk: mouse monoclonal anti-calpain-3
(dilution 1:50) (CALP12A2, Novocastra, Newcastle upon Tyne, UK), mouse monoclonal anti-
p53 (dilution 1:1000) (SC-126, Santa Cruz Biotechnology, Santa Cruz, CA), and rabbit poly-
clonal anti-PARP1/2 (dilution 1:1000) (SC-7150, Santa Cruz Biotechnology,). After incubation
with horseradish peroxidase-conjugated secondary antibodies (Sigma-Aldrich) at room tem-
perature for 1 h, protein bands were visualized by an enhanced chemiluminescence reaction
system (Super Signal West Pico, Thermo Scientific, Rockford, IL). Membranes were then devel-
oped on Hyperfilm ECL (Amersham GE Healthcare, UK) and protein bands were quantified
by densitometric analysis (image processing software ImageJ). Before adding primary antibod-
ies, equal gel loading, quality control, and transfer efficiency among samples were assessed by
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reversible Ponceau S protein staining on membranes. Equal loading was also assessed by
mouse monoclonal anti-β-actin-HRP conjugated antibody (dilution 1:50,000) (Sigma-
Aldrich).
PCR Array
Gene expression analysis in transfected cells was carried out by using RT2 Profiler PCR Array:
Human Oxidative Stress (PAHS-065Z, Qiagen), following manufacturer’s instructions. Briefly,
total RNA was extracted with RNeasy Mini Kit (Qiagen), and genomic DNA was removed by
using in-column DNA digestion (Qiagen). Total RNA (1 μg) was retro-transcribed by using
RT2 First Strand Kit (Qiagen), with Oligo dTs as primers. The obtained cDNA was used for
Real-Time PCR detection with RT2 SYBR Green/ROX qPCRMasterMix (Qiagen). Amplifica-
tion protocol was set up according to manufacturer’s instructions for Applied Biosystems Ste-
pOnePlus instrument (Applied Biosystems, Foster City, CA). Data were analyzed by using
Web-based PCR Array Data Analysis Software at: http://sabiosciences.com/
pcrarraydataanalysis.php.
Real-Time PCR analysis
RNA was extracted as above described. cDNA was obtained from 1 μg of total RNA using High
Capacity cDNA Reverse Transcription Kit (Invitrogen Life Technologies) and random prim-
ers. Gene expression level was measured in triplicates by Real-Time PCR, using StepOnePlus
(Applied Biosystems) and Power SYBR Green PCR Master Mix (Invitrogen Life Technologies),
and normalized to the endogenous reference gene β-Actin (S1 Table for the primers used).
The thermocycling conditions were: 10 minutes at 95°C, followed by 40 cycles of denaturation
(95°C for 15 s) and 60°C for 1 minute, for annealing and extension. Melting curve analysis was
used to confirm specificity of the obtained results. Gene expression values in hMp84-
transfected cells were expressed as fold-change over empty vector-transfected cells, using 2-ΔΔc
(t) parameter [14].
Statistics
Results are presented as mean ± SE, and the statistical significance of the differences among the
groups was determined by the Student’s t-test. Where stated, results are presented as mean
ratio (over EV-cells) ± 95% confidence interval, and the statistical significance was determined
by means of 95% confidence interval.
Results
Calpain-3 over-expression in A375 melanoma cells
In order to over-express the Calpain-3 variant hMp84 (hereafter called p84) in human melano-
ma cells, preliminary experiments performed in a few cell lines were aimed to produce stably-
transfected cells, through selection of neomycin-resistant clones; unfortunately, we failed to ob-
tain stable p84 over-expressing cells, since they all died after 7–10 days of selection. The obser-
vation that melanoma cells do not tolerate long-lasting, high levels of such Calpain-3 variant
was a starting and useful indication about the detrimental effect of this protease to melanoma
cells, and prompted us to perform experiments in transiently over-expressing cells. For the ma-
jority of these experiments, A375 melanoma cells were chosen, due to their satisfactory trans-
fection efficiency (about 40%). After transfection, the expression level of p84 protein was
evaluated at different time points. As shown in Fig. 1A and B, in empty vector-transfected cells
(hereafter called EV-cells) the full-length p84 is hardly detectable, while in p84 over-expressing
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cells (hereafter called p84-cells) there is a significant amount of the full-length protein, along
with a few additional bands, including a major one of approximately 60 kDa. As we have previ-
ously shown by means of a different antibody [4] and similarly to what happens in muscle Cal-
pain-3 [15], these additional bands derive from p84 (auto)proteolysis. In adhering cells, the
full-length p84 protein reaches a peak at 24 h, decreasing at 48 h and disappearing at 72 h after
transfection. As expected, a huge increase of hMp84 mRNA is also observed at 24 h after trans-
fection in p84-cells (RT-PCR data not shown), compared to non-transfected cells and EV-cells.
Calpain-3 over-expression inhibits cell proliferation and induces cell
death in A375 cells
Compared to EV-cells, p84-cells show a significant, progressive decrease of cell proliferation,
evaluated as total cell number (Fig. 1C). Concomitantly, a notable time-dependent increase of
floating cells detached from the monolayer is observed, as a first indication of an ongoing cell
damage and eventual cell demise (Fig. 1D). Interestingly, p84 expression, which is lost in still
adhering cells at 72 h, is enduring at this time in floating, detached cells (Fig. 1B), indicating
that the longer lasting p84 expression is just associated to cell damage.
To investigate the early molecular events induced by p84 over-expression, the majority of
our investigations were performed at 24 h after transfection. In order to explore the mode of
cell death, which was preliminarily indicated by cell detachment, we measured the release of
the intracellular LDH enzyme in culture medium. As shown in Fig. 2A, the remarkable increase
of released LDH clearly indicates that a damage at plasmamembrane occurs. Along with such
necrotic-like cell death, an apoptotic mode of cell demise also occurs, as shown by the occur-
rence of typical apoptotic hallmarks: the significant amount of nuclei showing an apoptotic
morphology (Fig. 2B and S1 Fig.), the significant activation of the effector caspases-3/7
Fig 1. Transient over-expression of Calpain-3 (variant hMp84) impairs cell proliferation and leads to cell detachment in A375 melanoma cells. At
24, 48 and 72 h after transfection, hMp84 protein (p84) was evaluated byWestern blot in empty vector- (EV) and in hMp84-transfected cells (p84), both in still
adhering, viable cells (A) and in floating cells (B), separately harvested. A typical Western blot out of three is shown. At the same times after transfection, cell
proliferation (total cell number) (C) and cell detachment (% of floating cells on total cells) (D) were evaluated in parental, non-transfected cells (W), in EV-cells
and in p84-cells. Results are presented as mean ± S.E. of at least four independent experiments. *P<0.05; **P<0.01.
doi:10.1371/journal.pone.0117258.g001
Calpain-3 in Proliferation and Death of Melanoma Cells
PLOS ONE | DOI:10.1371/journal.pone.0117258 February 6, 2015 7 / 22
(Fig. 2C), and the caspases-3/7-mediated proteolytic cleavage of poly(ADP-ribose) polymerase
(PARP) (Fig. 2D).
Calpain-3 over-expression induces p53 activation and redox imbalance
in A375 cells
To give insights into the mechanism responsible for apoptotic cell death in p84-cells, we mea-
sured the expression level of a central regulator of susceptibility to apoptosis, i.e. the tumor
suppressor protein p53, whose levels are regulated by several stress conditions, including DNA
damage, hypoxia, and changes in the redox potential [16]. As shown in Fig. 2E, p53 protein sig-
nificantly accumulates in p84-cells compared to EV-cells, and such an increase, which is higher
at 24 h, mirrors the expression of p84. Along with the stabilization of p53 protein, which does
not result from higher mRNA levels (RT-PCR data not shown), its transcriptional activity is
also increased, as demonstrated by the expression level of a major p53 target gene,WAF1/
CIP1, which is 1.7-fold ± 0.1 (mean ± S.E., n = 4, p<0.05) in p84-cells over EV-cells.
In order to evaluate the early events occurring in p84-cells, the biomolecular parameters re-
ported below were measured in adhering cells, where viability is still maintained. Among the
stress signals that can lead to p53 stabilization and activation, DNA damage is believed to play
a central role. To verify this instance, we measured the basal level of DNA damage by alkaline
Comet assay. Higher levels of DNA damage are observed in p84-cells as compared to EV-cells
(Fig. 3A), along with an increased level of “hedgehog comets” (S2 Fig.), the latter possibly rep-
resenting a non-specific indicator of the earliest stages of apoptosis [17,18]. While the signifi-
cance of hedgehog comets in apoptosis is still debated [18], it is however well established that a
Fig 2. hMp84 stimulates cell death and stabilizes p53 protein in A375 melanoma cells. At 24 h after
transfection, cell death was evaluated in EV-cells and in p84-cells as amount of intracellular LDH released in
the culture medium (A), as percentage of nuclei showing an apoptotic morphology (Hoechst 33258 staining)
(B), as caspase-3/-7 activation (enzymatic activity) (C), and as caspase-mediated proteolysis of poly(ADP-
ribose) polymerase (PARP) (a typical Western blot experiment out of three is shown) (D). Results are
presented as mean ± S.E. of three to six independent experiments. *P<0.05 and ***P<0.001, compared to
control EV-cells. At 24, 48 and 72 h after transfection, p53 protein was evaluated byWestern blot (E), in EV-
cells and p84-cells. A typical Western blot out of three is shown.
doi:10.1371/journal.pone.0117258.g002
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Comet positivity is a reliable and sensitive measure of DNA damage, also induced by
oxidative stress.
Polyunsaturated fatty acids in membranes lipids can be also modified when a redox imbal-
ance occurs, and lipid peroxidation is a major consequence of oxidative damage, virtually in all
cell type. A series of prostaglandin F2-like compounds, named F2-isoprostanes (F2-IsoPs), are
formed by free radical-catalyzed, non-enzymatic peroxidation of esterified arachidonic acid in
phospholipids. F2-IsoPs are chemically stable compounds that are measurable in an accurate
and reproducible way, down to the order of picograms; therefore, they are considered specific,
sensitive and reliable markers of oxidative stress/lipid peroxidation [19]. A significant amount
of total F2-IsoPs (esterified plus non-esterified) is formed in p84-cells, as compared to EV-cells
(Fig. 3B), indicating that cellular membranes (plasmamembrane and/or organelle membranes)
undergo lipid peroxidation. In particular, the oxidative alteration of plasmamembrane, which
leads to loss of plasmamembrane integrity, could account for the leakage of the intracellular
LDH enzyme, as above shown.
In order to directly evaluate whether p84-cells experience an oxidative stress, we measured
the intracellular formation of Reactive Oxygen Species (ROS) in intact adhering cells by using
the DCF-based assay. A significant amount of oxidant species is formed in p84-cells as com-
pared to EV-cells, at 24 h after transfection (Fig. 3C). In addition to intracellular sources of
Fig 3. hMp84 induces DNA damage and oxidative alterations of phospholipids in A375melanoma
cells, by stimulating the formation of Reactive Oxygen Species (ROS). In EV-cells and in p84-cells at 24
h after transfection, DNA damage (by means of Comet assay) (A) and total (esterified plus non-esterified) F2-
isoprostanes were measured (B). In intact EV-cells and p84-cells, the formation of ROS was measured in the
intracellular milieu (by DCF-based assay) (C), or in the extracellular milieu (by A6550-based assay) with or
without the NADPH-oxidase inhibitor, DPI (10 μM), added in the assay mixture (D). Results are presented as
mean ± S.E. of two independent experiments performed in duplicate (DNA comets), four independent
experiments (F2-isoprostanes), or six independent experiments (ROS formation). Results in panel D are
presented as mean ratio (over EV-cells) ± 95% confidence interval of three independent experiments.
*P<0.05, **P<0.01, and ***P<0.001, compared to control EV-cells. n.s.: non-significant, compared to p84-
cells without DPI.
doi:10.1371/journal.pone.0117258.g003
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ROS, which include mitochondrial electron transport chain, cytochromes and, specifically for
melanoma cells, melanin metabolism, NADPH oxidase is also considered an important en-
zyme for extracellular ROS production in melanoma cells [20]. Thus, we investigated whether
NADPH oxidase contributes to p84-mediated ROS formation, by using the horseradish peroxi-
dase-linked Amplex Red assay, which measures oxidant species outside the cells. As shown in
Fig. 3D, an increase of extracellular peroxides is observed in p84-cells, as compared to EV-cells.
However, the NADPH oxidase inhibitor, DPI, added in the in vitro assay, does not inhibit such
ROS formation, suggesting that NADPH oxidase (at least that working at plasmamembrane
level) is not responsible for such redox imbalance, and the measured extracellular ROS are
most likely delivered by the intracellular milieu.
To gain further insights into the molecular events underlying the observed oxidative imbal-
ance, in adhering cells at 24 h after transfection we analyzed the expression level of diverse oxi-
dative stress-related genes, by using RT2 Profiler PCR Array: Human Oxidative Stress. Out of
84 genes evaluated in the array, 13 genes show expression changes by at least 1.5-fold or 0.5-
fold in p84-cells over control EV-cells. For three selected genes showing the highest gene ex-
pression changes, Real Time-PCR analysis was performed in additional independent experi-
ments in order to confirm the results obtained by microarray analysis (Table 1). The overall
trend of gene expression changes confirms that p84-cells experience an oxidative imbalance.
This is consistent with the positive modulation of two genes coding for proteins involved in the
production of ROS: NCF2, coding for Neutrophilic Cytosolic Factor-2 (p67-Phox), which is a
cytosolic activating component of the NADPH oxidase-2 (NOX2) complex, and NOX4, coding
for the catalytic subunit of NADPH oxidase-4. A different set of genes coding for proteins en-
dowed with various antioxidant properties are also positively regulated, including GPX2 and
GPX3 coding for Glutathione Peroxidase-2 and-3, SELS coding for Selenoprotein S, GCLM
coding for the modifier subunit of the Glutamate-cysteine ligase (the limiting first enzyme for
Glutathione (GSH) biosynthesis), and SOD2 coding for the mitochondrial Superoxide Dismut-
ase. SOD enzyme, since detoxifies superoxide anion but converts the latter in another oxidant
specie (i.e. hydrogen peroxide), can be also regarded as involved in ROS metabolism. Among
the antioxidants, it is also observed a significant down-regulation of GSTZ1 (coding for Gluta-
thione Transferase Z-1), whose deficiency has been proved to induce an oxidative stress and a
compensatory up-regulation of GCLM [21]. Moreover, a few other genes considered oxidative
stress-responsive genes (Table 1) are also up-regulated in p84-cells.
Calpain-3-mediated cell injury in A375 cells is prevented by NAC and
pifithrin-α
To understand whether the redox imbalance occurring in p84-cells has a causative role in cell
proliferation impairment and in cell injury, we treated EV- and p84-cells with the antioxidant
N-acetyl-cysteine (NAC) [22]. While efficiently preventing the formation of intracellular ROS
in p84-cells at 12 h (Fig. 4A) and 24 h (Fig. 4B) after transfection, NAC treatment significantly
recovers viability of p84-cells, as revealed by the lower number of detached cells (Fig. 5A),
along with a remarkable decrease of both LDH release (Fig. 5B) and caspase-3/-7 activity
(Fig. 5C). These NAC-mediated effects suggest that an antioxidant environment is able to
counteract both an apoptotic and necrotic cell damage in p84-cells. On the contrary, no signifi-
cant restoration of cell proliferation is afforded by NAC (data not shown).
To investigate the role played by p53 stabilization in p84-cells, we treated EV- and p84-cells
with pifithrin-α (PFT), a compound which reversibly inhibits the transcriptional activity of
p53 [23]. PFT treatment decreases to some extent the hMp84-mediated cell injury, as firstly in-
dicated by the lower percentage of detached cells (Fig. 5A). Such a protection is mainly effective
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on apoptotic cell death, as shown by the remarkable inhibition of caspase-3/-7 activity
(Fig. 5C); on the contrary, no protective effect is evident on plasmamembrane damage
(Fig. 5B). As concerns the pro-oxidant status in p84-cells, p53 inhibition by PFT completely
abrogates ROS formation at early times (12 h) (Fig. 4A) after transfection, but such effect is lost
at 24 h (Fig. 4B), possibly due to the reversible, and hence transient, inhibition of p53 by PFT.
Similarly to NAC treatment, PFT treatment is not able to recover cell proliferation (data not
shown).
Calpain-3 over-expression affects cell proliferation, and stimulates cell
death and oxidant species formation in HT-144 melanoma cells
The major findings obtained in A375 cells were confirmed in HT-144 melanoma cells over-
expressing hMp84 (p84-cells). As shown in Fig. 6A, in empty vector-transfected cells (EV-
cells) p84 is hardly detectable, while in p84-cells there is a notable amount of the protein at 24
h after transfection. As expected, a huge increase of hMp84 mRNA is also observed in p84-cells
(RT-PCR data not shown), compared to non-transfected cells and EV-cells. Similarly to A375
cells, at 24 h after transfection, Calpain-3 over-expression lowers cell proliferation, evaluated as
total cell number (Fig. 6C), compared to EV-cells. A remarkable increase of floating cells de-
tached from the monolayer is also observed, as a first indication of ongoing cell damage and
eventual cell demise (Fig. 6D). In HT-144 p84-cells, cell death occurs indeed, as documented
by the remarkable release of intracellular LDH in culture medium (Fig. 6E), by the significant
amount of nuclei showing an apoptotic morphology (Fig. 6F and S3 Fig.), and by the significant
Table 1. Gene expression analysis of oxidative stress-related genes in A375 melanoma cells over-expressing hMp84.
Gene symbol (accession number) Description Gene name Fold-change
Genes involved in ROS Production/Metabolism
NCF2 (NM_000433) Neutrophil cytosolic factor 2 P67-PHOX 2.54 ± 0.32 p<0.01
NOX4 (NM_016931) NADPH oxidase 4 RENOX 1.7
SOD2 (NM_000636) Superoxide dismutase 2, mitochondrial MNSOD 1.6
Oxidative Stress-Responsive Genes, encoding Antioxidants
GPX2 (NM_002083) Glutathione peroxidase 2 GSHPx-2 1.9
GPX3 (NM_002084) Glutathione peroxidase 3 GSHPx-3 1.5
SELS (NM_203472) Selenoprotein S ADO15 1.5
GCLM (NM_002061) Glutamate-cysteine ligase, modifier subunit GLCLR 1.6
GSTZ1 (NM_001513) Glutathione transferase zeta 1 GSTZ1–1 0.44 ± 0.05 p<0.01
*SOD2 (NM_000636) Superoxide dismutase 2, mitochondrial MNSOD 1.6
Oxidative Stress Responsive Genes
CCL5 (NM_002985) Chemokine (C-C motif) ligand 5 RANTES 2.75 ± 0.45 p<0.05
DUSP1 (NM_004417) Dual specificity phosphatase 1 MKP-1 1.7
FTH1 (NM_002032) Ferritin, heavy polypeptide 1 PIG15 1.5
HMOX1 (NM_002133) Heme oxygenase 1 HO-1 1.5
PTGS2 (NM_000963) Prostaglandin G/H synthase and cyclooxygenase COX-2 1.5
Gene expression was analyzed in triplicate samples by using RT2 Profiler PCR Array—Human Oxidative Stress. For NCF2, GSTZ1 and CCL5, three
additional independent experiments in triplicates were performed by RT-PCR. Gene expression values in p84-cells are expressed as fold-change (mean ±
S.E.) over EV-cells after 24 h of transfection.
*SOD2 has been included both in genes involved in Reactive Oxygen Species (ROS) production/metabolism and in oxidative stress-responsive genes,
encoding antioxidants.
doi:10.1371/journal.pone.0117258.t001
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activation of caspases-3/-7 (Fig. 6G). Differently from A375 cells, no accumulation of p53 pro-
tein in observed at 24 h after transfection (Fig. 6B).
hMp84 over-expression also alters the redox state in HT-144 cells, as shown by the in-
creased level of intracellular Reactive Oxygen Species (revealed by the DCF-based assay)
formed in p84-cells compared to EV-cells (Fig. 7A). Such redox imbalance leads to lipid perox-
idation of plasmamembrane and/or organelle membranes, as revealed by the increased forma-
tion of F2-isoprostanes in p84-cells (Fig. 7B).
Fig 4. Treatment with the antioxidantN-Acetyl-L-Cysteine (NAC) or with the p53 inhibitor, Pifithrin-α
(PFT), prevents ROS formation in hMp84-overexpressing A375 cells. At 12 h (A) and 24 h (B) after
transfection, ROS formation was evaluated by DCF-based assay in EV-cells and p84 cells, incubated with or
without NAC (5 mM) or PFT (1 μM). Results are presented as mean ± S.E. of six (A) or three (B) independent
experiments. *P<0.05; **P<0.01; n.s.: non-significant.
doi:10.1371/journal.pone.0117258.g004
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Over-expression of mutant Calpain-3 (hMp84C42S) does not affect cell
fate in both A375 and HT-144 melanoma cells
In order to understand whether the observed cellular events required a potentially active Cal-
pain-3, in selected experiments we overexpressed the mutant hMp84C42S (virtually devoid of
Fig 5. Treatment with the antioxidantN-Acetyl-L-Cysteine (NAC) or with the p53 inhibitor, Pifithrin-α
(PFT), prevents cell death in hMp84-overexpressing A375 cells. At 24 h after transfection, in EV- and
p84-cells, incubated with or without NAC (5 mM) or PFT (1 μM), cell death was evaluated as percentage of
floating cells on total cells (A), as LDH released in the culture medium (B), and as caspase-3/-7 enzymatic
activity (C). Results are presented as mean ± S.E. of three (A and B) or five (C) independent experiments.
*P<0.05, **P<0.01, ***P<0.001; n.s.: non-significant.
doi:10.1371/journal.pone.0117258.g005
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its enzymatic activity) in both melanoma cell lines. First of all, in hMp84C42S–overexpressing
cells (hereafter called p84m-cells) the amount of full-length hMp84C42S is comparable to the
overexpressed full-length hMp84. The pattern of fragments at lower molecular weight is also
comparable, although it is quantitatively lighter in HT-144 p84m-cells (Fig. 8A and B). The
similarity of the proteolysis pattern between hMp84 and hMp84C42S suggests that autolysis of
this Calpain-3 variant is not relevant as for muscle Calpain-3, and other proteases are likely re-
sponsible for the observed processing. As concerns the biological effects of the mutant variant,
Fig 6. Transient over-expression of hMp84 impairs cell proliferation and stimulates cell death in HT-
144 melanoma cells. All parameters were evaluated at 24 h after transfection. (A) hMp84 protein (p84) was
evaluated byWestern blot in adhering cells of empty vector- (EV) and hMp84-transfected cells (p84); a typical
Western blot out of three is shown. (B) p53 protein was evaluated byWestern blot; a typical experiment out of
four is shown. (C) Cell proliferation (total cell number) and (D) cell detachment (% of floating cells on total
cells) were evaluated in parental, non-transfected cells (W), in EV- and in p84-cells. Cell death was evaluated
as amount of intracellular LDH released in the culture medium (E), as percentage of nuclei showing an
apoptotic morphology (Hoechst 33258 staining) (F), and as caspase-3/-7 enzymatic activity (G). Results are
presented as mean ± S.E. of at least five independent experiments. *P<0.05; **P<0.01; ***P<0.001.
doi:10.1371/journal.pone.0117258.g006
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at 24 h after transfection, with the exception of a minor decrease of the total cell number in
A375 p84m-cells (p = 0.046), p84m-cells do not show neither increase of cell detachment
(which is a first sign of cell damage and eventual cell death) nor significant decrease of total cell
number, compared to EV-cells (Fig. 8C-F). These results suggest that a potentially active
hMp84 is required for its detrimental effects in melanoma cells.
Discussion
Calpain-3 is a Ca2+-regulated cysteine protease, predominantly expressed in skeletal muscle,
where it is essential to maintain healthy conditions of this tissue. The importance of its activity
has been clearly assessed in human muscles, where several described missense mutations in the
gene, giving a protease devoid of its proteolytic activity, are responsible for Limb Girdle
Fig 7. hMp84 stimulates the formation of Reactive Oxygen Species (ROS) and induces oxidative
alterations of phospholipids in HT-144melanoma cells. At 24 h after transfection, the formation of
intracellular ROS (by DCF-based assay) (A) and total (esterified plus non-esterified) F2-isoprostanes (B)
were measured in adhering EV- and p84-cells. Results are presented as mean ± S.E. of three to five
independent experiments. *P<0.05.
doi:10.1371/journal.pone.0117258.g007
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Muscular Dystrophy type 2A (LGMD2A), an autosomal recessive disease characterized by pro-
gressive atrophy and weakness of the proximal limb muscles [2,24]. Muscle Calpain-3 under-
goes a rapid autoproteolysis (both in vivo and in vitro), which leads to its enzymatic activation
[25]. Its relative instability makes difficult the identification of physiological substrates other
than itself. However, in various experimental settings (mainly in vitro assays), diverse cleavage
substrates have been suggested [3,15,26–31], a few of which shared with conventional calpains.
Several variants of Calpain-3 have been reported in many normal mammalian cells [32], in-
cluding rodent ocular tissues [33,34] and astrocytes [35], and human lymphocytes [36], thus
suggesting that Calpain-3 is also important for tissues other than skeletal muscle. As concerns
tumor cells, a very short variant 6 has been identified in melanoma cells [32]; this variant is
down-regulated in drug-induced terminal differentiation of melanoma cells, but its over-
expression does not significantly affect growth kinetics and cell viability [8]. A previous study
of our group has identified two novel splicing variants of CAPN3, namely hMp78 and hMp84,
Fig 8. Over-expression of hMp84mutated in the active site (hMp84C42S) does not affect cell fate in
both A375 and HT-144 melanoma cells. All parameters were evaluated at 24 h after transfection.
hMp84C42S protein was evaluated byWestern blot in adhering and floating cells of A375- (A) and HT-144-
transfected cells (B); typical Western blots out of three are shown. Cell proliferation (total cell number) was
evaluated in parental, non-transfected cells (W), in EV- and in hMp84C42S-cells of A375 (C) and HT-144 cells
(D). Cell detachment was evaluated in EV- and in hMp84C42S-cells of A375 (E) and HT-144 cells (F). Results
are presented as mean ± S.E. of at least three independent experiments. NS = non-significant and *P = 0.046
compared to EV-cells.
doi:10.1371/journal.pone.0117258.g008
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in human melanoma cell lines and melanocytic lesions [4], both variants displaying an atypical
initiation exon, instead of the canonical NS-encoding exon 1, and the shorter variant lacking
the IS1-coding exon 6. On the basis of this previous work, which also suggested an active role
of these isoforms in the apoptotic machinery of melanoma cells, in the present study we have
further investigated the biological role of the longer variant hMp84 in this tumor cell type.
In A375 and in HT-144 melanoma cells over-expressing hMp84 (p84-cells), we observe a
variety of significant changes compared to control EV-cells. It is worthwhile to highlight that
the transfection efficiency obtained by us is partial (around 40 and 30%, in A375 and HT-144
cells, respectively), thus all observed changes, as measured in the whole cell population, are
even underestimated. First of all, a significant production of Reactive Oxygen Species (ROS)
occurs. Several intracellular sources of ROS have been proposed in melanoma cells [37–39],
such as the mitochondrial electron transport chain [40], considered the major source in meta-
bolically very active tumor cells, NADPH oxidases (mainly Nox4) [41,42] and, as unique fea-
ture of these melanocytes-derived tumor cells, the aberrant melanin biosynthesis and oxidation
[43]. Among these, we have not strictly ascertained which is the source of ROS in p84-cells;
however, the results obtained in A375 cells suggest that the major production of ROS derives
from the intracellular milieu. In this respect, the significantly increased gene expression of
NCF2, coding for the cytosolic activating component p67-Phox of the plasmamembrane
NOX2 complex, could potentially contribute to intracellular ROS generation, in case that in
melanoma cells NOX2 is located also into intracellular membranes, as demonstrated in differ-
ent cell types [41].
As a compensatory attempt to protect themselves against a ROS-mediated cell injury, A375
p84-cells tend to up-regulate, albeit mildly, several genes encoding for antioxidant enzymes. In
this antioxidant context, the remarkable down-regulation of GSTZ1 needs to be valued from a
different perspective. GSTZ1 codes for a member of Glutathione-S-transferases, which catalyze
the conjugation of glutathione (GSH) to a variety of electrophilic substances [44], including ox-
idative stress-generated products, and also modulate cell signaling pathways that control cell
proliferation and apoptosis [45]. Interestingly, a deficiency of GSTZ1 has been demonstrated
to cause oxidative stress and activation of antioxidant pathways, including the modifier subunit
of glutamate-cysteine ligase, the limiting enzyme for glutathione biosynthesis [21]. All these
mechanisms are expected to be operative also in p84-cells, where a significant down-regulation
of GSTZ1 occurs.
Over the past few years, many evidences have highlighted the subtle balance existing be-
tween p53 and redox homeostasis: on one hand, ROS can oxidize cysteine residues of p53,
modifying its conformational status and transcriptional activity; on the other hand, p53 can in-
fluence cellular ROS production, by activating or repressing many ROS-regulating genes cod-
ing for pro-oxidant or anti-oxidant proteins [46]. In our study, Calpain-3-overexpressing A375
cells show both a significant accumulation of p53 (wild-type in these cells) and expression
changes of several oxidative stress-related genes which are also p53-target genes (such as
NCF2, SOD2, GPX2, GPX3) [46–49], suggesting that p53 plays a role in the complex network
of ROS regulation. Since ROS are actually formed, at levels sufficient to induce oxidative modi-
fication of both DNA and phospholipids, we can argue that the contribution of p53 in the
redox homeostasis results in a net shift of the redox balance toward a pro-oxidant status. This
is also confirmed by the prevention of ROS formation afforded by PFT-α, an inhibitor of p53
transcriptional activity. However, a p53-independent mechanism for ROS formation must be
also considered. In Calpain-3-overexpressing HT-144 cells, in fact, the increased formation of
ROS is not accompanied by up-regulation of p53 protein (wild-type also in these cells). This is
likely due to homozygous mutation in ATM (Ataxia Telangiectasia Mutated) gene [50], that is
an important player in p53 activation. Interestingly, the fact that no increase of p53
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transcriptional activity is expected to occur in HT-144 p84-cells extends the biological role of
Calpain-3 to those tumor types (including melanomas to some extent) harbouring TP53muta-
tions which impair p53 transcriptional activity.
It is well known that ROS, acting as second messengers, modulate multiple cell signalling
pathways, and such pleiotropic effect can result in opposite cell fates [51]. Redox alterations
due to elevated ROS produced by different physiological sources have been proved to be benefi-
cial for diverse tumor types, including melanoma [37,39]. By favouring tumor cell proliferation
[20] and genomic instability [52], they contribute to cancer progression. On the other hand, it
is also well established (more than one hundred articles in PubMed) that an excessive or lasting
ROS production can culminate in apoptotic death of melanoma cells. Here, we show that mela-
noma cells with enforced expression of Calpain-3 experience a redox imbalance and, judging
on their adverse cell fate (i.e. stimulation of cell death), we can say that they experience an oxi-
dative stress. The causative role of such oxidative stress in the loss of cell viability is substantiat-
ed, first, by the significant protection against cell death afforded by the antioxidant NAC.
Second, the causative role of p53-dependent oxidative stress is also indicated by the partial res-
cue occurring in PFT-α-treated cells; in these p53-inhibited cells, however, additional anti-apo-
ptotic mechanisms can be also evoked [16].
While efficiently preventing ROS formation and cell death, the antioxidant NAC is not able
to restore the proliferation of Calpain-3-overexpressing cells, suggesting that ROS do not play
a major role in impairing cell growth in this experimental context. Rather, Calpain-3 could di-
rectly effect a degradative processing or a regulatory modification (through limited proteolysis)
of target proteins involved in cell cycle control. Consistently, in different cells over-expressing
the muscle-specific Calpain-3, a number of proteolyzed substrates have been identified, includ-
ing components of the protein synthesis apparatus, glycolytic enzymes [26], and β-catenin
[29]. Interestingly, β-catenin, a key component of Wnt pathway proved to be often up-regulat-
ed in melanomas [53], co-activates transcription factors involved in cell proliferation, survival
and migration. In this context, the proteolytic activity of hMp84 could negatively control the
basal or up-regulated level of free β-catenin.
A further event occurring in A375 cells is the significantly increased expression of RANTES,
an oxidative stress—responsive gene coding for CCL5 chemokine. It has been reported that
CCL5 is secreted by melanoma cells in vivo and in vitro, and is able to recruit diverse tumor-in-
filtrating leucocytes (TIL) [54,55]. Interestingly, in various experimental settings (in in vitro
treated melanoma cells, in melanoma-bearing mice, and in melanoma patients), an overall an-
titumor effect of this cytokine has been demonstrated [54]. These findings are consistent with
our results, where up-regulation of RANTES in Calpain-3-overexpressing cells could contribute
to the impairment of cell growth and to cell death.
As concerns the catalytic versus structural role of Calpain-3, it was demonstrated that
knock-in mice which express a structurally intact but protease-inactive Calpain-3 (C129S mu-
tant) have a dystrophic muscle phenotype less severe than CAPN3−/−mice, thus proving that
muscle Calpain-3 also has a structural, non-proteolytic function [56]. Differently, in our exper-
imental setting the absence of macroscopic signs of cell damage in cells overexpressing
hMp84C42S (virtually devoid of enzymatic activity) allows us to conclude that hMp84 catalytic
activity is required for the observed detrimental effects in melanoma cells.
In conclusion, in the present study we show that in melanoma cells high levels of virtually
active Calpain-3 (variant hMp84) stimulate a variety of mechanisms which are eventually det-
rimental for cells, including p53 accumulation, modulation of several oxidative stress-related
genes, increased formation of ROS (Reactive Oxygen Species) leading to oxidative modification
of phospholipids, and DNA damage. A potential role of Calpain-3 in melanoma progression
can be envisaged, consistently with our previous observations showing lower expression level
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(compared to benign lesions) of both Calpain-3 variants, hMp78 and hMp84, in vertical
growth phase melanomas and, even lower, in metastases [4]. These most aggressive pheno-
types, in fact, are expected to benefit from down-regulation of mechanisms which impair cell
growth and stimulate cell death.
Supporting Information
S1 Fig. hMp84 induces an apoptotic nuclear morphology in A375 melanoma cells. Repre-
sentative fluorescence microscope images of Hoechst 33342-stained nuclei at 24 h after trans-
fection; 10x (left panels) and 40x (right panels) magnification. Empty vector-transfected cells
(EV-cells) and hMp84-transfected cell (p84-cells). Arrows indicate condensed and fragmented
nuclei. Scale bar = 50 μm.
(TIF)
S2 Fig. hMp84 induces DNA damage in A375 melanoma cells. Representative fluorescence
microscope images of comets. (A) Empty vector-transfected cells (EV-cells); (B) hMp84-trans-
fected cell (p84-cells); (C) a hedgehog comet in p84-cells. Scale bars = 10 μm.
(TIF)
S3 Fig. hMp84 induces an apoptotic nuclear morphology in HT-144 melanoma cells. Repre-
sentative fluorescence microscope images of Hoechst 33342-stained nuclei at 24 h after trans-
fection; 10x (left panels) and 40x (right panels) magnification. Empty vector-transfected cells
(EV-cells) and hMp84-transfected cell (p84-cells). Arrows indicate condensed and fragmented
nuclei. Scale bar = 50 μm.
(TIF)
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